Dairy foods and dairy proteins in the management of type 2 diabetes: a systematic review of the clinical evidence
- PMID: 25979490
- PMCID: PMC4424779
- DOI: 10.3945/an.114.007690
Dairy foods and dairy proteins in the management of type 2 diabetes: a systematic review of the clinical evidence
Abstract
Type 2 diabetes mellitus (T2DM) is a growing public health concern affecting hundreds of millions of people worldwide and costing the global economy hundreds of billions of dollars annually. This chronic disease damages the blood vessels and increases the risk of other cardiometabolic ailments such as cardiovascular disease and stroke. If left unmanaged it can also lead to nerve damage, kidney damage, blindness, and amputation. For the most part, many of these symptoms can be prevented or reduced through simple dietary modifications and proper nutrition. Therefore, identifying relatively inexpensive and easily implementable dietary modifications for the prevention and management of T2DM is of considerable value to human health and healthcare modalities around the globe. Protein-rich dairy products have consistently been shown in epidemiologic studies to be beneficial for reducing the risk of developing T2DM. The clinical evidence regarding both dairy foods and dairy proteins (i.e., casein and whey protein) have shown promise for improving insulin secretion in individuals with T2DM. However, the clinical research on dairy protein supplementation in subjects with T2DM has been limited to acute studies. These studies have been mostly descriptive and have not been focused on important T2DM endpoints such as prevention, management, or treatment. Long-term studies are clearly needed to help researchers and medical professionals better understand the effects of consistent dairy protein intake on the metabolic health of humans with T2DM.
Keywords: casein; cultured; dairy; fermented; glucose; insulin; milk; protein; type 2 diabetes; whey.
© 2015 American Society for Nutrition.
Conflict of interest statement
Author disclosures: G Pasin is the executive director of the California Dairy Research Foundation. KB Comerford is a paid consultant for the California Dairy Research Foundation. All conclusions are the work of the authors.
Figures
References
-
- Shamseddeen H, Getty JZ, Hamdallah IN, Ali MR. Epidemiology and economic impact of obesity and type 2 diabetes. The Surgical clinics of North America 2011;91(6):1163–72, vii. - PubMed
-
- Whiting DR, Guariguata L, Weil C, Shaw J. IDF Diabetes atlas: Global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract 2011;94:311–21. - PubMed
-
- Lazarou C, Panagiotakos D, Matalas AL. The role of diet in prevention and management of type 2 diabetes: implications for public health. Crit Rev Food Sci Nutr 2012;52:382–9. - PubMed
-
- Hagura R. Diabetes mellitus and life-style–for the primary prevention of diabetes mellitus: the role of diet. Br J Nutr 2000;84: Suppl 2:S191–4. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
